• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INION OY INION CPS 1.5/2.0/2.5 BIOABSORBABLE FIXATION SYSTEM; BONE SCREW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INION OY INION CPS 1.5/2.0/2.5 BIOABSORBABLE FIXATION SYSTEM; BONE SCREW Back to Search Results
Model Number SCR-2225
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Cellulitis (1768); Foreign Body Reaction (1868)
Event Date 01/11/2021
Event Type  Injury  
Manufacturer Narrative
Inion cps 2.0 4-hole plate and 2x7mm screws were used for fixation after intraorbital tumor resection in (b)(6)-year old patient (i.E., pediatric patient).Six days postoperatively there was redness and swelling of the upper eyelid accompanied by pus in the lateral canthus.Treatment with intravenous antibiotics did not resolve the problem.It is unclear whether bacterial culture was made before choosing the antibiotic (ceftriaxone sodium).Approximately 3 weeks postoperatively reoperation number 1 was carried out for abscess incision and drainage.3 months later (i.E., approximately 4 months and 10 days after the original tumor resection operation and implantation of the inion cps implants) problems reoccurred with orbit skin ulceration and cellulitis inflammation.Two weeks later (i.E., nearly 5 months after the original tumor resection operation and implantation of the inion cps implants) reoperation number 2 was carried out for implant removal and debridement.Most likely the initial cause of the complications experienced by the above described patient was bacterial infection.The patient was treated with intravenous antibiotics (ceftriaxone sodium) initially but that didn't solve the problem.The early onset of symptoms (6 days postoperatively) indicates bacterial infection (or possibly swelling due to surgical trauma) rather than tissue reaction related to the implant material because typically implant material degradation related inflammatory tissue reactions occur much later, i.E., typically 1-2 years postoperatively in case of the inion cps implants, and only very rarely as early as 0,5-1 years after implantation).
 
Event Description
Right intraorbital tumor resection for (b)(6) year old female patient was operated.Redness and swelling developed 6 days after the operation.There was no significant improvement after intravenous infusion of ceftriaxone sodium, so "orbit sidewise opening of the right eye, intraorbital abscess incision and drainage, orbital septum repair, eyelid suture" were carried out 3 weeks post operatively.4 months after the initial operation,the skin of the right orbit was ulcerated.The diagnosis was "right orbit cellulitis inflammation".And revision surgery was performed.At implant removal granulation-like tissue hyperplasia was seen and removed, the soft tissue near the absorbable plate was eroded and brittle.There was no obvious infection in the exploration, and the outer orbital bone was healed well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INION CPS 1.5/2.0/2.5 BIOABSORBABLE FIXATION SYSTEM
Type of Device
BONE SCREW
Manufacturer (Section D)
INION OY
lääkärinkatu 2
tampere, 33520
FI  33520
Manufacturer (Section G)
INION OY
lääkärinkatu 2
tampere, 33520
FI   33520
Manufacturer Contact
kati marttinen
lääkärinkatu 2
tampere, 33520
FI   33520
MDR Report Key11559134
MDR Text Key244385730
Report Number3003407235-2021-00001
Device Sequence Number1
Product Code HWC
UDI-Device Identifier06438408001185
UDI-Public06438408001185
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K010352
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSCR-2225
Device Catalogue NumberSCR-2225
Device Lot Number2005003
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/22/2021
Initial Date FDA Received03/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age6 YR
Patient Weight22
-
-